COYA

Coya Therapeutics, Inc.

6.06 USD
+0.01 (+0.17%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Coya Therapeutics, Inc. stock is down -25.64% since 30 days ago. The next earnings date is Aug 6, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 0% of the previous 1 June’s closed higher than May. 100% of analysts rate it a buy.

About Coya Therapeutics, Inc.

We are a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells. We were incorporated under the laws of the state of Delaware on November 23, 2020 under the name Coya Therapeutics, Inc. On December 22, 2020, we consummated the Corporate Reorganization pursuant to which all of the issued and outstanding stock of Nicoya Health, Inc., a Delaware corporation formed in 2020, were exchanged for common stock of Coya Therapeutics, Inc. Our principal executive offices are located at 5850 San Felipe St, Suite 500, Houston, TX.

  • Rodman & Renshaw
    Thu Jun 13, 13:30
    buy
    initial
  • Chardan Capital
    Wed Jun 5, 16:15
    buy
    confirm